Perspective Therapeutics CATX
NYSE CATX
$2.29 +0.10 (+4.57%)
As of: Oct 20, 2026 · 3:59 PM EDT

Perspective Therapeutics (CATX) Interest Paid (2011 - 2012)

Updated

Analysis

Perspective Therapeutics (CATX) Interest Paid (2011 - 2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Paid (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 339.00 Mn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 1.07 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 1.25 Bn
10 Perspective Therapeutics 279.31 Mn 42.41 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 6.00
Dec 31, 2011 -17.00
Sep 30, 2011 94.00
API Access

Perspective Therapeutics Interest Paid API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-paid&ticker=CATX&period=max&api_key=YOUR_API_KEY